$10 Million 'Eat Me' Award: California Stem Cell Agency to Firm Called Forty Seven
The California stem cell agency is set this week to award $10 million to a Menlo Park firm to help finance a clinical trial for a therapy for colon cancer, which is the second leading cause of cancer death in this country.
The cash will go to Forty Seven, Inc., an enterprise using an immune system, "eat me" technology developed at Stanford University by …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.